 | • レポートコード：QYR2104Z1454 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、結腸直腸がん分子診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（PCR診断、質量分析診断、その他）、用途別市場規模（病院、外来手術センター、診断研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・結腸直腸がん分子診断の市場動向 ・企業の競争状況、市場シェア ・結腸直腸がん分子診断の種類別市場規模（PCR診断、質量分析診断、その他） ・結腸直腸がん分子診断の用途別市場規模（病院、外来手術センター、診断研究所） ・結腸直腸がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・結腸直腸がん分子診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・結腸直腸がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結腸直腸がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・結腸直腸がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Agilent、Hologic、Qiagen、Roche、Bayer、Abbott、Grifols、Danaher、Siemens、BD、Biomérieux、Sysmex） ・結論 |
Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine. Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.
Market Analysis and Insights: Global Colorectal Cancer Molecular Diagnostics Market
The global Colorectal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Molecular Diagnostics market.
Global Colorectal Cancer Molecular Diagnostics Scope and Market Size
Colorectal Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR Diagnostics
Mass spectrometry Diagnostics
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Agilent
Hologic
Qiagen
Roche
Bayer
Abbott
Grifols
Danaher
Siemens
Roche
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR Diagnostics
1.2.3 Mass spectrometry Diagnostics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Colorectal Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Colorectal Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Colorectal Cancer Molecular Diagnostics Market Trends
2.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
2.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
2.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Molecular Diagnostics Revenue
3.4 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Revenue in 2020
3.5 Colorectal Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)
5 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Details
11.1.2 Agilent Business Overview
11.1.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
11.1.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Agilent Recent Development
11.2 Hologic
11.2.1 Hologic Company Details
11.2.2 Hologic Business Overview
11.2.3 Hologic Colorectal Cancer Molecular Diagnostics Introduction
11.2.4 Hologic Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Hologic Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
11.3.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Qiagen Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Colorectal Cancer Molecular Diagnostics Introduction
11.4.4 Roche Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Colorectal Cancer Molecular Diagnostics Introduction
11.5.4 Bayer Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
11.6.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Grifols
11.7.1 Grifols Company Details
11.7.2 Grifols Business Overview
11.7.3 Grifols Colorectal Cancer Molecular Diagnostics Introduction
11.7.4 Grifols Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Grifols Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Colorectal Cancer Molecular Diagnostics Introduction
11.8.4 Danaher Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Danaher Recent Development
11.9 Siemens
11.9.1 Siemens Company Details
11.9.2 Siemens Business Overview
11.9.3 Siemens Colorectal Cancer Molecular Diagnostics Introduction
11.9.4 Siemens Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Siemens Recent Development
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Colorectal Cancer Molecular Diagnostics Introduction
11.10.4 BD Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 BD Recent Development
11.11 Biomérieux
11.11.1 Biomérieux Company Details
11.11.2 Biomérieux Business Overview
11.11.3 Biomérieux Colorectal Cancer Molecular Diagnostics Introduction
11.11.4 Biomérieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.11.5 Biomérieux Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Details
11.12.2 Sysmex Business Overview
11.12.3 Sysmex Colorectal Cancer Molecular Diagnostics Introduction
11.12.4 Sysmex Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
11.12.5 Sysmex Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR Diagnostics
Table 3. Key Players of Mass spectrometry Diagnostics
Table 4. Key Players of Others
Table 5. Global Colorectal Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Colorectal Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Colorectal Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 9. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 11. Colorectal Cancer Molecular Diagnostics Market Trends
Table 12. Colorectal Cancer Molecular Diagnostics Market Drivers
Table 13. Colorectal Cancer Molecular Diagnostics Market Challenges
Table 14. Colorectal Cancer Molecular Diagnostics Market Restraints
Table 15. Global Colorectal Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Colorectal Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 17. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2020)
Table 18. Ranking of Global Top Colorectal Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
Table 22. Date of Enter into Colorectal Cancer Molecular Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 26. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Colorectal Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 30. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Agilent Company Details
Table 63. Agilent Business Overview
Table 64. Agilent Colorectal Cancer Molecular Diagnostics Product
Table 65. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 66. Agilent Recent Development
Table 67. Hologic Company Details
Table 68. Hologic Business Overview
Table 69. Hologic Colorectal Cancer Molecular Diagnostics Product
Table 70. Hologic Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 71. Hologic Recent Development
Table 72. Qiagen Company Details
Table 73. Qiagen Business Overview
Table 74. Qiagen Colorectal Cancer Molecular Diagnostics Product
Table 75. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 76. Qiagen Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Colorectal Cancer Molecular Diagnostics Product
Table 80. Roche Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Bayer Company Details
Table 83. Bayer Business Overview
Table 84. Bayer Colorectal Cancer Molecular Diagnostics Product
Table 85. Bayer Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 86. Bayer Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Colorectal Cancer Molecular Diagnostics Product
Table 90. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Grifols Company Details
Table 93. Grifols Business Overview
Table 94. Grifols Colorectal Cancer Molecular Diagnostics Product
Table 95. Grifols Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 96. Grifols Recent Development
Table 97. Danaher Company Details
Table 98. Danaher Business Overview
Table 99. Danaher Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 100. Danaher Recent Development
Table 101. Siemens Company Details
Table 102. Siemens Business Overview
Table 103. Siemens Colorectal Cancer Molecular Diagnostics Product
Table 104. Siemens Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 105. Siemens Recent Development
Table 106. BD Company Details
Table 107. BD Business Overview
Table 108. BD Colorectal Cancer Molecular Diagnostics Product
Table 109. BD Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 110. BD Recent Development
Table 111. Biomérieux Company Details
Table 112. Biomérieux Business Overview
Table 113. Biomérieux Colorectal Cancer Molecular Diagnostics Product
Table 114. Biomérieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 115. Biomérieux Recent Development
Table 116. Sysmex Company Details
Table 117. Sysmex Business Overview
Table 118. Sysmex Colorectal Cancer Molecular Diagnostics Product
Table 119. Sysmex Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 120. Sysmex Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Diagnostics Features
Figure 3. Mass spectrometry Diagnostics Features
Figure 4. Others Features
Figure 5. Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Colorectal Cancer Molecular Diagnostics Report Years Considered
Figure 10. Global Colorectal Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Colorectal Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 13. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 14. Global Colorectal Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 15. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue in 2020
Figure 17. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 18. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 19. North America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 21. North America Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 22. North America Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 23. United States Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 27. Europe Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 28. Europe Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 29. Germany Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 39. China Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 47. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 48. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 49. Mexico Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 55. Turkey Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Agilent Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 59. Hologic Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Qiagen Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Grifols Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Danaher Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Siemens Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. BD Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Biomérieux Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Sysmex Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnostics & Therapeutics Market The global Colorectal Cancer Diagnostics & Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …